EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $577,245 | -68.2% | 36,604 | -46.7% | 0.00% | -75.0% |
| Q3 2022 | $1,815,000 | -62.2% | 68,686 | -36.4% | 0.01% | -60.0% |
| Q2 2022 | $4,796,000 | -30.4% | 107,947 | -22.5% | 0.02% | -16.7% |
| Q1 2022 | $6,893,000 | -7.6% | 139,273 | -4.9% | 0.02% | 0.0% |
| Q4 2021 | $7,458,000 | -0.1% | 146,473 | +9.5% | 0.02% | -7.7% |
| Q3 2021 | $7,462,000 | +26.5% | 133,773 | -3.0% | 0.03% | +23.8% |
| Q2 2021 | $5,901,000 | -0.9% | 137,873 | -3.4% | 0.02% | -19.2% |
| Q1 2021 | $5,955,000 | +25.2% | 142,673 | +39.7% | 0.03% | +23.8% |
| Q4 2020 | $4,756,000 | -9.7% | 102,120 | -17.6% | 0.02% | 0.0% |
| Q3 2020 | $5,264,000 | +63.5% | 123,920 | +84.7% | 0.02% | +31.2% |
| Q2 2020 | $3,219,000 | +1.9% | 67,087 | -2.3% | 0.02% | -20.0% |
| Q1 2020 | $3,160,000 | -38.3% | 68,692 | -19.4% | 0.02% | +17.6% |
| Q4 2019 | $5,122,000 | -15.1% | 85,258 | -20.0% | 0.02% | -22.7% |
| Q3 2019 | $6,032,000 | -20.5% | 106,622 | -21.7% | 0.02% | -18.5% |
| Q2 2019 | $7,586,000 | +875.1% | 136,235 | +784.6% | 0.03% | +800.0% |
| Q1 2019 | $778,000 | +135.0% | 15,400 | +222.9% | 0.00% | +200.0% |
| Q3 2018 | $331,000 | – | 4,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |